A detailed history of High Point Advisor Group LLC transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, High Point Advisor Group LLC holds 613 shares of BIO stock, worth $196,350. This represents 0.01% of its overall portfolio holdings.

Number of Shares
613
Holding current value
$196,350
% of portfolio
0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$263.97 - $344.64 $161,813 - $211,264
613 New
613 $205,000
Q4 2023

Mar 26, 2024

SELL
$269.37 - $365.04 $156,773 - $212,453
-582 Reduced 48.87%
609 $196,000
Q2 2022

Aug 15, 2022

BUY
$463.67 - $597.16 $59,813 - $77,033
129 Added 12.15%
1,191 $607,000
Q3 2021

Nov 15, 2021

SELL
$657.71 - $825.77 $52,616 - $66,061
-80 Reduced 7.01%
1,062 $792,000
Q2 2021

Jul 29, 2021

BUY
$576.64 - $649.04 $85,919 - $96,706
149 Added 15.01%
1,142 $736,000
Q1 2021

Apr 12, 2021

BUY
$547.01 - $662.35 $86,427 - $104,651
158 Added 18.92%
993 $598,000
Q4 2020

Feb 10, 2021

BUY
$510.68 - $643.45 $45,450 - $57,267
89 Added 11.93%
835 $531,000
Q3 2020

Nov 06, 2020

BUY
$454.43 - $535.6 $41,353 - $48,739
91 Added 13.89%
746 $470,000
Q2 2020

Aug 13, 2020

BUY
$334.87 - $493.06 $40,519 - $59,660
121 Added 22.66%
655 $298,000
Q1 2020

May 01, 2020

BUY
$320.01 - $409.07 $96,963 - $123,948
303 Added 131.17%
534 $231,000
Q1 2020

Apr 27, 2020

BUY
$320.01 - $409.07 $73,922 - $94,495
231 New
231 $534,000
Q4 2019

Feb 13, 2020

SELL
$319.73 - $374.2 $131,089 - $153,422
-410 Closed
0 $0
Q3 2019

Nov 12, 2019

BUY
$304.55 - $345.24 $4,568 - $5,178
15 Added 3.8%
410 $144,000
Q2 2019

Aug 15, 2019

BUY
$286.93 - $312.59 $113,337 - $123,473
395 New
395 $123,000

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $7.89B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track High Point Advisor Group LLC Portfolio

Follow High Point Advisor Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Point Advisor Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Point Advisor Group LLC with notifications on news.